Last update: Nov. 21, 2018
Minimal risk for breastfeeding and infant.
It is excreted into breast milk in low (Aoki 2018, Naito 2015) or undetectable concentration (Morgan 2018), without problems observed in infants whose mothers were on treatment with this drug. (Naito 2015, Szucs 2010, Ahn 2007).
When measured, the plasma levels of drug in these infants were undetectable (Aoki 2018, Morgan 2018, Vasa 2013 S15-poster 29).
Because its drug elimination period is very prolonged, safer known alternatives may be preferable, especially during the neonatal period and in case of premature infant.
However, the measurements, which have been undetectable, have been made in newborns, in the first week of life, and several of them were premature (Aoki 2018).
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.